Free Trial
→ Washington Thinks They Own Your Bank Account (From Priority Gold) (Ad) Free THG Stock Alerts

The Hanover Insurance Group (THG) Financials

The Hanover Insurance Group logo
$169.24 -0.34 (-0.20%)
As of 11:58 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for The Hanover Insurance Group

Annual Income Statements for The Hanover Insurance Group

This table shows The Hanover Insurance Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 332 155 186 391 425 359 423 116 35 426
Consolidated Net Income / (Loss)		 332 155 186 391 425 359 423 116 35 426
Net Income / (Loss) Continuing Operations		 331 67 216 239 429 362 420 117 34 425
Total Pre-Tax Income 		439 66 293 283 522 445 521 144 41 538
Total Revenue		 4,988 4,173 4,228 4,464 4,747 4,801 5,075 5,500 5,973 6,195
Net Interest Income / (Expense)		 -61 -51 -45 -45 -38 -37 -34 -34 -34 -34
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 61 51 45 45 38 37 34 34 34 34
Long-Term Debt Interest Expense		 61 51 45 45 38 37 34 34 34 34
Total Non-Interest Income		 5,048 4,225 4,274 4,510 4,784 4,838 5,109 5,534 6,007 6,229
Other Service Charges		 31 23 23 23 26 27 24 27 31 28
Net Realized & Unrealized Capital Gains on Investments		 313 413 271 237 286 283 315 255 313 288
Premiums Earned		 4,705 3,790 3,980 4,254 4,475 4,527 4,770 5,252 5,663 5,913
Total Non-Interest Expense		 4,548 4,107 3,935 4,139 4,331 4,353 4,672 5,292 5,926 5,675
Property & Liability Insurance Claims		 2,884 2,546 2,580 2,725 2,866 2,845 3,134 3,623 4,135 3,757
Other Operating Expenses		 631 730 510 522 539 557 555 574 608 690
Amortization Expense		 1,033 804 841 892 927 951 983 1,093 1,176 1,222
Impairment Charge		 - 27 5.60 - - - - 1.90 7.70 5.80
Nonoperating Income / (Expense), net		 - - - -43 107 - 119 -63 -5.60 14
Income Tax Expense		 109 -1.00 77 44 93 83 101 27 7.60 113
Net Income / (Loss) Discontinued Operations		 0.70 -1.00 -30 152 -3.90 -3.30 2.80 -0.80 1.80 0.70
Basic Earnings per Share		 $7.55 $3.63 $4.38 $9.21 $10.62 $9.52 $11.78 $3.26 $0.99 $11.85
Weighted Average Basic Shares Outstanding		 43.90M 42.80M 42.50M 42.40M 40M 37.70M 35.90M 35.60M 35.70M 35.90M
Diluted Earnings per Share		 $7.40 $3.59 $4.33 $9.09 $10.46 $9.42 $11.60 $3.21 $0.98 $11.70
Weighted Average Diluted Shares Outstanding		 44.80M 43.20M 43M 43M 40.60M 38.10M 36.40M 36.10M 36.10M 36.40M
Weighted Average Basic & Diluted Shares Outstanding		 43.90M 42.70M 42.50M 40.57M 38.45M 36.39M 35.48M 35.60M 35.82M 35.93M

Quarterly Income Statements for The Hanover Insurance Group

This table shows The Hanover Insurance Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 0.50 -12 -12 -69 8.60 108 116 41 102 168 128
Consolidated Net Income / (Loss)		 0.50 -12 -12 -69 8.60 108 116 41 102 168 128
Net Income / (Loss) Continuing Operations		 0.60 -12 -12 -70 8.20 107 116 40 102 167 128
Total Pre-Tax Income 		0.50 -15 -18 -91 -0.90 150 145 51 130 212 160
Total Revenue		 1,366 1,518 1,442 1,499 1,513 1,519 1,536 1,531 1,546 1,583 1,594
Net Interest Income / (Expense)		 -8.50 -8.60 -8.50 -8.60 -8.50 -8.50 -8.50 -8.60 -8.50 -8.50 -8.50
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 8.50 8.60 8.50 8.60 8.50 8.50 8.50 8.60 8.50 8.50 8.50
Long-Term Debt Interest Expense		 8.50 8.60 8.50 8.60 8.50 8.50 8.50 8.60 8.50 8.50 8.50
Total Non-Interest Income		 1,395 1,456 1,451 1,507 1,522 1,527 1,545 1,539 1,554 1,591 1,602
Other Service Charges		 7.00 7.10 8.00 7.80 7.40 7.60 7.30 7.60 6.70 6.40 6.40
Net Realized & Unrealized Capital Gains on Investments		 73 70 78 88 83 64 88 58 68 73 87
Premiums Earned		 1,331 1,364 1,380 1,412 1,431 1,440 1,449 1,473 1,479 1,512 1,509
Other Non-Interest Income		 -16 - -15 - - - 0.30 - - - 0.00
Total Non-Interest Expense		 1,357 1,486 1,453 1,588 1,509 1,376 1,397 1,480 1,428 1,370 1,435
Property & Liability Insurance Claims		 940 1,051 1,017 1,140 1,062 916 935 1,008 954 861 955
Other Operating Expenses		 141 150 147 154 151 156 163 166 165 196 165
Amortization Expense		 277 284 289 293 297 298 299 304 308 311 314
Nonoperating Income / (Expense), net		 -29 - -7.10 -1.10 -5.20 7.80 6.50 1.10 12 -5.10 1.00
Income Tax Expense		 -0.10 -2.80 -5.50 -21 -9.10 43 30 11 28 44 32
Basic Earnings per Share		 $0.01 ($0.34) ($0.34) ($1.94) $0.24 $3.03 $3.22 $1.13 $2.84 $4.66 $3.56
Weighted Average Basic Shares Outstanding		 35.60M 35.60M 35.60M 35.70M 35.80M 35.70M 35.80M 36M 36M 35.90M 36M
Diluted Earnings per Share		 $0.01 ($0.33) ($0.34) ($1.94) $0.24 $3.02 $3.18 $1.12 $2.80 $4.60 $3.50
Weighted Average Diluted Shares Outstanding		 36.10M 36.10M 35.60M 35.70M 36.10M 36.10M 36.30M 36.30M 36.50M 36.40M 36.60M
Weighted Average Basic & Diluted Shares Outstanding		 35.56M 35.60M 35.73M 35.75M 35.76M 35.82M 35.94M 35.98M 36.03M 35.93M 35.92M

Annual Cash Flow Statements for The Hanover Insurance Group

This table details how cash moves in and out of The Hanover Insurance Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -35 -56 94 648 -808 -95 110 74 11 120
Net Cash From Operating Activities		 445 743 705 551 603 708 824 722 362 806
Net Cash From Continuing Operating Activities		 445 743 705 188 603 708 824 722 362 806
Net Income / (Loss) Continuing Operations		 332 155 186 0.00 425 359 423 116 35 426
Consolidated Net Income / (Loss)		 332 155 186 - 425 359 423 116 35 426
Depreciation Expense		 30 31 30 -25 22 18 17 13 6.30 1.50
Amortization Expense		 13 9.90 14 9.70 11 6.00 3.40 5.50 7.90 6.80
Non-Cash Adjustments to Reconcile Net Income		 -21 92 -11 -224 -91 21 -100 135 63 107
Changes in Operating Assets and Liabilities, net		 91 456 486 790 235 304 481 453 249 265
Net Cash From Investing Activities		 -172 -495 -506 271 -312 -609 -460 -508 -229 -541
Net Cash From Continuing Investing Activities		 -172 -495 -506 271 -312 -609 -460 -508 -229 -541
Purchase of Property, Leasehold Improvements and Equipment		 -20 -16 -19 -13 -13 -15 -8.00 -18 -12 -10
Purchase of Investment Securities		 -2,222 -2,372 -1,878 -1,604 -1,921 -2,084 -2,303 -2,085 -1,131 -3,313
Divestitures		 44 - - 636 35 0.00 0.00 0.00 0.00 0.00
Sale and/or Maturity of Investments		 2,026 1,892 1,390 1,253 1,587 1,490 1,851 1,595 914 2,782
Net Cash From Financing Activities		 -301 -301 -112 -171 -1,099 -194 -253 -141 -122 -146
Net Cash From Continuing Financing Activities		 -301 -301 -112 -171 -1,099 -194 -253 -141 -122 -146
Repurchase of Common Equity		 -127 -106 -37 -58 -564 -213 -163 -31 0.00 -27
Payment of Dividends		 -74 -80 -87 -94 -386 -100 -102 -109 -117 -124
Other Financing Activities, Net		 15 -10 12 -7.40 1.60 -2.20 12 -0.90 -4.90 5.30
Other Net Changes in Cash		 - - - - 3.30 0.00 0.00 0.00 0.00 -0.60
Cash Interest Paid		 61 53 48 48 37 34 33 33 33 33
Cash Income Taxes Paid		 57 30 51 57 114 97 74 108 -22 149

Quarterly Cash Flow Statements for The Hanover Insurance Group

This table details how cash moves in and out of The Hanover Insurance Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 19 140 -124 -14 127 22 -52 77 86 8.60 -121
Net Cash From Operating Activities		 315 199 18 26 225 93 59 140 395 214 39
Net Cash From Continuing Operating Activities		 315 199 18 26 225 93 59 140 395 214 39
Net Income / (Loss) Continuing Operations		 0.50 -12 -12 -69 8.60 108 116 41 102 168 128
Consolidated Net Income / (Loss)		 0.50 -12 -12 -69 8.60 108 116 41 102 168 128
Depreciation Expense		 3.80 2.90 2.20 1.80 1.50 0.80 0.80 0.80 0.50 -0.60 -1.10
Amortization Expense		 1.40 1.40 2.00 2.00 1.90 2.00 1.70 1.70 1.70 1.70 1.60
Non-Cash Adjustments to Reconcile Net Income		 53 -25 30 11 15 7.90 1.20 43 21 42 25
Changes in Operating Assets and Liabilities, net		 257 232 -4.00 81 198 -26 -61 54 269 2.50 -115
Net Cash From Investing Activities		 -259 -31 -107 -12 -68 -42 -75 -34 -282 -150 -112
Net Cash From Continuing Investing Activities		 -259 -31 -107 -12 -68 -42 -75 -34 -282 -150 -112
Purchase of Property, Leasehold Improvements and Equipment		 -4.00 -3.90 -3.50 -3.30 -2.90 -2.20 -2.60 -2.20 -2.40 -3.00 -1.80
Purchase of Investment Securities		 -474 -563 -283 -206 -313 -329 -304 -935 -957 -1,118 -828
Sale and/or Maturity of Investments		 219 536 180 198 248 289 232 903 677 970 717
Net Cash From Financing Activities		 -38 -27 -35 -29 -29 -29 -35 -29 -27 -55 -48
Net Cash From Continuing Financing Activities		 -38 -27 -35 -29 -29 -29 -35 -29 -27 -55 -48
Repurchase of Common Equity		 -10 - 0.00 - - - 0.00 - - -27 -11
Payment of Dividends		 -27 -29 -29 -29 -29 -30 -31 -31 -31 -32 -32
Other Financing Activities, Net		 -0.50 1.90 -6.20 0.40 -0.40 1.30 -4.90 2.00 3.90 4.30 -4.10
Other Net Changes in Cash		 - - - - - - - - - -0.20 0.50

Annual Balance Sheets for The Hanover Insurance Group

This table presents The Hanover Insurance Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 13,781 14,220 15,470 12,400 12,491 13,444 14,254 13,995 14,613 15,275
Cash and Due from Banks		 339 283 298 1,021 216 121 231 305 316 436
Trading Account Securities		 7,560 7,916 6,326 6,626 7,263 8,053 8,385 7,724 8,116 8,700
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 63 62 48 53 53 51 50 55 58 70
Unearned Premiums Asset		 1,392 1,438 1,096 1,177 1,260 1,339 1,470 1,601 1,706 1,801
Deferred Acquisition Cost		 509 518 430 451 467 478 552 605 621 663
Goodwill		 186 185 179 179 179 179 179 179 179 179
Other Assets		 3,733 3,820 7,094 2,894 3,052 3,223 3,388 3,527 3,617 3,427
Total Liabilities & Shareholders' Equity		 13,781 14,220 15,470 12,400 12,491 13,444 14,254 13,995 14,613 15,275
Total Liabilities		 10,937 11,363 12,472 9,445 9,574 10,242 11,109 11,661 12,147 12,433
Short-Term Debt		 - - - - - - - - 0.00 62
Other Short-Term Payables		 725 728 - 910 628 688 908 732 776 758
Long-Term Debt		 803 786 787 778 653 781 782 782 783 722
Claims and Claim Expense		 6,574 6,949 5,059 5,304 5,654 6,024 6,448 7,013 7,308 7,461
Unearned Premiums Liability		 2,541 2,561 2,132 2,278 2,417 2,483 2,735 2,954 3,103 3,283
Other Long-Term Liabilities		 294 338 4,495 175 222 267 238 181 177 146
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,844 2,858 2,998 2,955 2,916 3,202 3,145 2,334 2,466 2,842
Total Preferred & Common Equity		 2,844 2,858 2,998 2,955 2,916 3,202 3,145 2,334 2,466 2,842
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 2,844 2,858 2,998 2,955 2,916 3,202 3,145 2,334 2,466 2,842
Common Stock		 1,834 1,847 1,858 1,872 1,838 1,858 1,888 1,914 1,940 1,974
Retained Earnings		 1,804 1,876 1,975 2,182 2,411 2,668 2,983 2,993 2,909 3,210
Treasury Stock		 -847 -928 -943 -984 -1,485 -1,696 -1,848 -1,871 -1,866 -1,886
Accumulated Other Comprehensive Income / (Loss)		 54 63 108 -117 153 373 122 -702 -517 -456

Quarterly Balance Sheets for The Hanover Insurance Group

This table presents The Hanover Insurance Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 13,746 14,092 14,187 14,315 14,594 14,872 15,367 15,470
Cash and Due from Banks		 165 182 168 295 265 338 427 315
Trading Account Securities		 7,600 7,913 7,831 7,742 8,153 8,198 8,770 8,969
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 50 54 56 56 58 62 64 66
Unearned Premiums Asset		 1,624 1,600 1,674 1,771 1,740 1,814 1,882 1,809
Deferred Acquisition Cost		 600 598 606 631 619 635 663 657
Goodwill		 179 179 179 179 179 179 179 179
Other Assets		 3,528 3,566 3,674 3,641 3,581 3,648 3,382 3,475
Total Liabilities & Shareholders' Equity		 13,746 14,092 14,187 14,315 14,594 14,872 15,367 15,470
Total Liabilities		 11,450 11,703 11,949 12,199 12,071 12,320 12,489 12,426
Short-Term Debt		 - - - - - - - 62
Other Short-Term Payables		 723 619 652 728 679 735 775 619
Long-Term Debt		 782 783 783 783 783 784 784 723
Claims and Claim Expense		 6,774 7,143 7,313 7,330 7,331 7,463 7,427 7,609
Unearned Premiums Liability		 2,972 2,969 3,021 3,188 3,105 3,168 3,339 3,259
Other Long-Term Liabilities		 199 189 180 170 173 170 164 155
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,296 2,389 2,238 2,116 2,523 2,552 2,878 3,044
Total Preferred & Common Equity		 2,296 2,389 2,238 2,116 2,523 2,552 2,878 3,044
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 2,296 2,389 2,238 2,116 2,523 2,552 2,878 3,044
Common Stock		 1,905 1,914 1,924 1,932 1,942 1,953 1,964 1,979
Retained Earnings		 3,030 2,952 2,853 2,832 2,994 3,003 3,075 3,307
Treasury Stock		 -1,873 -1,869 -1,868 -1,868 -1,864 -1,863 -1,861 -1,897
Accumulated Other Comprehensive Income / (Loss)		 -766 -608 -671 -780 -549 -541 -300 -345

Annual Metrics And Ratios for The Hanover Insurance Group

This table displays calculated financial ratios and metrics derived from The Hanover Insurance Group's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -0.28% -16.33% 1.32% 5.58% 6.32% 1.14% 5.71% 8.37% 8.60% 3.72%
EBITDA Growth		 11.23% -77.90% 216.14% -7.72% 44.24% 5.24% -10.44% -46.62% -73.02% 767.49%
EBIT Growth		 16.24% -84.98% 343.79% 11.27% 27.52% 7.77% -10.14% -48.50% -77.47% 1,013.49%
NOPAT Growth		 17.18% -79.75% 222.54% 27.59% 23.86% 6.01% -10.49% -48.11% -77.36% 987.81%
Net Income Growth		 17.55% -53.21% 20.05% 109.99% 8.72% -15.62% 17.87% -72.56% -69.57% 1,106.80%
EPS Growth		 17.83% -51.49% 20.61% 109.93% 15.07% -9.94% 23.14% -72.33% -69.47% 1,093.88%
Operating Cash Flow Growth		 -21.25% 67.17% -5.22% -21.76% 9.36% 17.37% 16.41% -12.31% -49.92% 122.95%
Free Cash Flow Firm Growth		 1,197.59% -83.61% 6.80% 334.64% 53.94% -110.19% 840.36% 157.14% -109.67% 139.07%
Invested Capital Growth		 -2.67% -0.10% 3.86% -1.37% -4.37% 11.58% -1.42% -20.64% 4.26% 11.61%
Revenue Q/Q Growth		 -1.85% -11.89% 0.92% 11.52% 2.30% 0.91% 0.59% 4.33% 0.04% 1.17%
EBITDA Q/Q Growth		 -6.95% -70.93% 148.53% -12.10% 29.39% 15.01% -8.80% -29.45% 227.41% 14.95%
EBIT Q/Q Growth		 -5.08% -79.66% 212.93% 3.49% 13.99% 16.52% -9.10% -31.02% 173.54% 15.66%
NOPAT Q/Q Growth		 -3.59% -72.78% 164.18% 2.16% 13.77% 14.13% -23.41% -42.32% 143.92% 20.19%
Net Income Q/Q Growth		 -3.58% -37.00% 53.63% 22.61% -3.14% 18.03% 0.71% -60.77% 141.68% 16.39%
EPS Q/Q Growth		 -3.14% -36.68% 53.55% 22.84% -1.32% 20.15% 2.75% -60.71% 141.35% 15.61%
Operating Cash Flow Q/Q Growth		 -12.97% 14.32% -1.54% -13.70% 18.49% -2.48% 8.90% -3.96% -22.63% 17.62%
Free Cash Flow Firm Q/Q Growth		 31.30% -23.92% -54.74% 21.96% 65.11% -137.69% -19.85% -10.81% -202.71% 108.85%
Invested Capital Q/Q Growth		 -1.16% -5.20% 0.69% -0.73% -4.93% 1.21% 1.10% 1.23% 12.05% -0.98%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 9.67% 2.55% 7.97% 6.97% 9.45% 9.83% 8.33% 4.10% 1.02% 8.53%
EBIT Margin		 8.81% 1.58% 6.93% 7.30% 8.76% 9.33% 7.93% 3.77% 0.78% 8.39%
Profit (Net Income) Margin		 6.65% 3.72% 4.40% 8.76% 8.96% 7.47% 8.33% 2.11% 0.59% 6.88%
Tax Burden Percent		 75.44% 235.00% 63.57% 138.41% 81.42% 80.64% 81.10% 80.56% 85.89% 79.21%
Interest Burden Percent		 100.00% 100.00% 100.00% 86.68% 125.63% 99.31% 129.52% 69.46% 88.01% 103.42%
Effective Tax Rate		 24.72% -1.52% 26.22% 15.40% 17.83% 18.62% 19.43% 18.89% 18.49% 20.92%
Return on Invested Capital (ROIC)		 8.95% 1.84% 5.82% 7.34% 9.35% 9.59% 8.19% 4.78% 1.20% 12.05%
ROIC Less NNEP Spread (ROIC-NNEP)		 9.03% 12.92% 2.02% 22.07% 21.04% 9.13% 20.84% -1.89% 0.84% 13.57%
Return on Net Nonoperating Assets (RNNOA)		 2.71% 3.60% 0.54% 5.80% 5.13% 2.14% 5.13% -0.54% 0.28% 4.01%
Return on Equity (ROE)		 11.66% 5.44% 6.36% 13.14% 14.48% 11.73% 13.32% 4.23% 1.47% 16.05%
Cash Return on Invested Capital (CROIC)		 11.65% 1.94% 2.03% 8.72% 13.82% -1.36% 9.62% 27.79% -2.97% 1.08%
Operating Return on Assets (OROA)		 3.19% 0.47% 1.97% 2.34% 3.34% 3.45% 2.91% 1.47% 0.33% 3.48%
Return on Assets (ROA)		 2.41% 1.11% 1.25% 2.81% 3.42% 2.77% 3.05% 0.82% 0.25% 2.85%
Return on Common Equity (ROCE)		 11.66% 5.44% 6.36% 13.14% 14.48% 11.73% 13.32% 4.23% 1.47% 16.05%
Return on Equity Simple (ROE_SIMPLE)		 11.65% 5.43% 6.21% 13.23% 14.58% 11.20% 13.44% 4.97% 1.43% 14.99%
Net Operating Profit after Tax (NOPAT)		 331 67 216 276 341 362 324 168 38 414
NOPAT Margin		 6.63% 1.61% 5.11% 6.18% 7.19% 7.54% 6.39% 3.06% 0.64% 6.68%
Net Nonoperating Expense Percent (NNEP)		 -0.08% -11.09% 3.80% -14.73% -11.68% 0.46% -12.64% 6.67% 0.35% -1.52%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 91.19% 98.42% 93.07% 92.70% 91.24% 90.67% 92.07% 96.23% 99.22% 91.61%
Earnings before Interest and Taxes (EBIT)		 439 66 293 326 416 448 403 207 47 520
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 482 107 337 311 449 472 423 226 61 528
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.96 1.08 1.24 1.39 1.66 1.25 1.39 1.95 1.72 1.96
Price to Tangible Book Value (P/TBV)		 1.03 1.15 1.32 1.47 1.76 1.32 1.48 2.12 1.85 2.09
Price to Revenue (P/Rev)		 0.55 0.74 0.88 0.92 1.02 0.83 0.86 0.83 0.71 0.90
Price to Earnings (P/E)		 8.24 19.83 20.02 10.47 11.35 11.16 10.35 39.29 119.96 13.08
Dividend Yield		 2.67% 2.60% 2.32% 2.30% 5.88% 2.47% 2.32% 2.39% 2.77% 2.23%
Earnings Yield		 12.13% 5.04% 4.99% 9.55% 8.81% 8.96% 9.66% 2.55% 0.83% 7.64%
Enterprise Value to Invested Capital (EV/IC)		 0.88 0.98 1.11 1.03 1.47 1.17 1.26 1.62 1.45 1.63
Enterprise Value to Revenue (EV/Rev)		 0.64 0.86 1.00 0.86 1.11 0.97 0.97 0.92 0.79 0.96
Enterprise Value to EBITDA (EV/EBITDA)		 6.63 33.58 12.51 12.38 11.73 9.88 11.66 22.31 77.20 11.21
Enterprise Value to EBIT (EV/EBIT)		 7.28 54.24 14.40 11.81 12.67 10.41 12.24 24.29 100.68 11.39
Enterprise Value to NOPAT (EV/NOPAT)		 9.66 53.43 19.52 13.96 15.42 12.88 15.21 29.95 123.52 14.30
Enterprise Value to Operating Cash Flow (EV/OCF)		 7.19 4.82 5.99 6.98 8.73 6.59 5.98 6.97 13.00 7.34
Enterprise Value to Free Cash Flow (EV/FCFF)		 7.42 50.70 55.93 11.75 10.43 0.00 12.95 5.15 0.00 160.17
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.28 0.28 0.26 0.26 0.22 0.24 0.25 0.34 0.32 0.28
Long-Term Debt to Equity		 0.28 0.28 0.26 0.26 0.22 0.24 0.25 0.34 0.32 0.25
Financial Leverage		 0.30 0.28 0.27 0.26 0.24 0.23 0.25 0.29 0.33 0.30
Leverage Ratio		 4.84 4.91 5.07 4.68 4.24 4.24 4.36 5.16 5.96 5.63
Compound Leverage Factor		 4.84 4.91 5.07 4.06 5.33 4.21 5.65 3.58 5.25 5.82
Debt to Total Capital		 22.02% 21.58% 20.79% 20.84% 18.30% 19.60% 19.91% 25.11% 24.11% 21.63%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.70%
Long-Term Debt to Total Capital		 22.02% 21.58% 20.79% 20.84% 18.30% 19.60% 19.91% 25.11% 24.11% 19.92%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 77.98% 78.42% 79.21% 79.16% 81.70% 80.40% 80.09% 74.89% 75.89% 78.38%
Debt to EBITDA		 1.67 7.38 2.34 2.50 1.46 1.65 1.85 3.47 12.86 1.48
Net Debt to EBITDA		 0.96 4.73 1.45 -0.78 0.98 1.40 1.30 2.12 7.67 0.66
Long-Term Debt to EBITDA		 1.67 7.38 2.34 2.50 1.46 1.65 1.85 3.47 12.86 1.37
Debt to NOPAT		 2.43 11.74 3.64 2.82 1.91 2.16 2.41 4.65 20.58 1.89
Net Debt to NOPAT		 1.40 7.52 2.26 -0.88 1.28 1.82 1.70 2.84 12.27 0.84
Long-Term Debt to NOPAT		 2.43 11.74 3.64 2.82 1.91 2.16 2.41 4.65 20.58 1.74
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 431 71 75 328 504 -51 381 979 -95 37
Operating Cash Flow to CapEx		 2,280.51% 4,735.03% 3,788.17% 4,208.40% 4,533.08% 4,748.99% 10,296.25% 4,057.87% 3,039.50% 7,905.88%
Free Cash Flow to Firm to Interest Expense		 7.11 1.37 1.67 7.27 13.45 -1.39 11.19 28.70 -2.78 1.08
Operating Cash Flow to Interest Expense		 7.34 14.46 15.59 12.22 16.08 19.07 24.23 21.18 10.61 23.65
Operating Cash Flow Less CapEx to Interest Expense		 7.02 14.16 15.18 11.93 15.72 18.67 23.99 20.66 10.26 23.35
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.36 0.30 0.28 0.32 0.38 0.37 0.37 0.39 0.42 0.41
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 3,648 3,644 3,785 3,733 3,570 3,983 3,927 3,116 3,249 3,626
Invested Capital Turnover		 1.35 1.14 1.14 1.19 1.30 1.27 1.28 1.56 1.88 1.80
Increase / (Decrease) in Invested Capital		 -100 -3.60 141 -52 -163 413 -57 -810 133 377
Enterprise Value (EV)		 3,197 3,580 4,217 3,850 5,264 4,663 4,928 5,035 4,702 5,922
Market Capitalization		 2,732 3,076 3,728 4,093 4,827 4,002 4,377 4,558 4,235 5,573
Book Value per Share		 $65.77 $67.17 $70.58 $69.80 $74.03 $85.96 $88.39 $65.62 $68.94 $78.87
Tangible Book Value per Share		 $61.47 $62.82 $66.37 $65.57 $69.49 $81.16 $83.36 $60.60 $63.94 $73.90
Total Capital		 3,648 3,644 3,785 3,733 3,570 3,983 3,927 3,116 3,249 3,626
Total Debt		 803 786 787 778 653 781 782 782 783 784
Total Long-Term Debt		 803 786 787 778 653 781 782 782 783 722
Net Debt		 464 504 489 -243 438 660 551 477 467 349
Capital Expenditures (CapEx)		 20 16 19 13 13 15 8.00 18 12 10
Net Nonoperating Expense (NNE)		 -0.70 -88 30 -115 -84 3.30 -99 52 2.76 -12
Net Nonoperating Obligations (NNO)		 803 786 787 778 653 781 782 782 783 784
Total Depreciation and Amortization (D&A)		 43 41 44 -15 33 24 20 18 14 8.30
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $7.55 $3.63 $4.38 $9.21 $10.62 $9.52 $11.67 $3.26 $0.99 $11.85
Adjusted Weighted Average Basic Shares Outstanding		 43.90M 42.80M 42.50M 42.40M 40M 37.70M 35.90M 35.60M 35.70M 35.90M
Adjusted Diluted Earnings per Share		 $7.40 $3.59 $4.33 $9.09 $10.46 $9.42 $11.49 $3.21 $0.98 $11.70
Adjusted Weighted Average Diluted Shares Outstanding		 44.80M 43.20M 43M 43M 40.60M 38.10M 36.40M 36.10M 36.10M 36.40M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $10.62 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 42.82M 42.50M 42.50M 40.57M 38.45M 36.39M 35.48M 35.60M 35.82M 35.93M
Normalized Net Operating Profit after Tax (NOPAT)		 331 65 220 276 341 362 324 170 44 419
Normalized NOPAT Margin		 6.63% 1.57% 5.21% 6.18% 7.19% 7.54% 6.39% 3.09% 0.74% 6.76%
Pre Tax Income Margin		 8.81% 1.58% 6.93% 6.33% 11.00% 9.27% 10.27% 2.62% 0.69% 8.68%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 7.25 1.28 6.48 7.23 11.08 12.07 11.84 6.08 1.37 15.25
NOPAT to Interest Expense		 5.46 1.30 4.78 6.11 9.11 9.76 9.53 4.93 1.12 12.14
EBIT Less CapEx to Interest Expense		 6.93 0.98 6.07 6.94 10.73 11.67 11.60 5.56 1.02 14.95
NOPAT Less CapEx to Interest Expense		 5.14 1.00 4.37 5.82 8.75 9.36 9.30 4.41 0.77 11.84
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 22.38% 51.84% 46.62% 24.12% 90.85% 27.74% 24.17% 93.88% 332.01% 29.13%
Augmented Payout Ratio		 60.78% 119.92% 66.60% 38.87% 223.43% 87.06% 62.63% 120.43% 332.01% 35.40%

Quarterly Metrics And Ratios for The Hanover Insurance Group

This table displays calculated financial ratios and metrics derived from The Hanover Insurance Group's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 7.91% 17.67% 9.08% 15.91% 10.76% 0.01% 6.50% 2.13% 2.14% 4.22% 3.75%
EBITDA Growth		 -69.98% -72.07% -104.62% -309.78% -45.77% 297.81% 2,383.87% 161.42% 1,459.74% 47.31% 12.95%
EBIT Growth		 -78.67% -74.32% -108.04% -344.14% -52.22% 342.24% 1,437.50% 156.03% 2,641.86% 49.44% 14.63%
NOPAT Growth		 2.79% -106.32% -106.91% -188.96% -91.53% 1,088.61% 1,615.56% 163.03% 2,986.04% 68.42% 15.47%
Net Income Growth		 -98.53% -107.22% -111.44% -404.85% 1,620.00% 991.74% 1,062.50% 158.53% 1,087.21% 55.61% 11.00%
EPS Growth		 -98.94% -107.13% -111.72% -407.94% 2,300.00% 1,015.15% 1,035.29% 157.73% 1,066.67% 52.32% 10.06%
Operating Cash Flow Growth		 10.02% -13.05% -90.95% 204.65% -28.69% -53.30% 224.31% 432.44% 75.66% 130.31% -33.73%
Free Cash Flow Firm Growth		 875.16% 264.85% 36.80% -58.52% -78.38% -103.87% -105.55% -201.96% -468.19% -564.36% -1,535.30%
Invested Capital Growth		 -20.74% -20.64% -12.26% -9.93% -5.81% 4.26% 4.24% 10.43% 26.29% 11.61% 15.81%
Revenue Q/Q Growth		 5.68% 11.12% -4.89% 3.90% 0.98% 0.34% 1.67% -0.36% 0.99% 2.39% 0.70%
EBITDA Q/Q Growth		 -65.28% 157.04% -116.99% -1,283.87% 108.97% 1,785.71% -2.48% -62.78% 127.89% 78.10% -25.39%
EBIT Q/Q Growth		 -75.48% 257.78% -132.30% -761.54% 104.80% 3,211.63% -2.32% -63.91% 134.86% 80.49% -25.24%
NOPAT Q/Q Growth		 -49.62% -128.97% 29.25% -761.54% 104.80% 3,279.66% 8.46% -64.17% 134.96% 84.45% -25.64%
Net Income Q/Q Growth		 -97.80% -2,520.00% 0.83% -476.67% 112.43% 1,154.65% 7.04% -64.94% 152.10% 64.45% -23.65%
EPS Q/Q Growth		 -98.41% -3,400.00% -3.03% -470.59% 112.37% 1,158.33% 5.30% -64.78% 150.00% 64.29% -23.91%
Operating Cash Flow Q/Q Growth		 3,563.95% -37.00% -90.88% 44.75% 757.63% -58.75% -36.68% 137.65% 182.94% -45.91% -81.78%
Free Cash Flow Firm Q/Q Growth		 29.03% -4.88% -45.54% -37.95% -32.76% -117.04% 21.97% -1,040.68% -142.83% 69.26% -92.06%
Invested Capital Q/Q Growth		 -8.22% 1.23% 1.78% -4.76% -4.02% 12.05% 1.76% 0.90% 9.76% -0.98% 5.59%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 1.04% 2.40% -0.43% -5.73% 0.51% 9.56% 9.22% 3.44% 7.77% 13.52% 10.01%
EBIT Margin		 0.66% 2.12% -0.72% -5.98% 0.28% 9.38% 9.06% 3.28% 7.63% 13.45% 9.98%
Profit (Net Income) Margin		 0.04% -0.80% -0.83% -4.62% 0.57% 7.11% 7.52% 2.65% 6.61% 10.61% 8.04%
Tax Burden Percent		 100.00% 82.31% 68.57% 76.30% -955.56% 71.84% 79.49% 78.95% 78.72% 79.39% 80.08%
Interest Burden Percent		 5.56% -45.65% 168.27% 101.23% -20.93% 105.48% 104.46% 102.19% 110.01% 99.39% 100.63%
Effective Tax Rate		 -20.00% 0.00% 0.00% 0.00% 0.00% 28.56% 20.51% 21.25% 21.28% 20.90% 19.93%
Return on Invested Capital (ROIC)		 3.94% -1.06% -0.84% -7.65% 0.40% 12.57% 13.44% 4.95% 11.22% 19.51% 14.01%
ROIC Less NNEP Spread (ROIC-NNEP)		 -0.54% -1.29% -1.44% -8.48% 1.11% 13.36% 14.10% 5.07% 12.39% 19.07% 14.11%
Return on Net Nonoperating Assets (RNNOA)		 -0.16% -0.37% -0.43% -2.76% 0.39% 4.36% 4.49% 1.66% 3.89% 5.63% 3.97%
Return on Equity (ROE)		 3.78% -1.43% -1.27% -10.40% 0.79% 16.93% 17.93% 6.61% 15.11% 25.14% 17.99%
Cash Return on Invested Capital (CROIC)		 31.52% 27.79% 12.98% 7.76% 3.08% -2.97% 0.62% -1.63% -12.74% 1.08% -2.56%
Operating Return on Assets (OROA)		 0.25% 0.83% -0.29% -2.51% 0.12% 3.92% 3.83% 1.38% 3.15% 5.57% 4.15%
Return on Assets (ROA)		 0.01% -0.31% -0.33% -1.94% 0.24% 2.97% 3.18% 1.11% 2.73% 4.40% 3.35%
Return on Common Equity (ROCE)		 3.78% -1.43% -1.27% -10.40% 0.79% 16.93% 17.93% 6.61% 15.11% 25.14% 17.99%
Return on Equity Simple (ROE_SIMPLE)		 12.88% 0.00% -0.04% -4.15% -4.00% 0.00% 6.45% 10.68% 12.72% 0.00% 14.41%
Net Operating Profit after Tax (NOPAT)		 36 -10 -7.28 -63 3.01 102 110 40 93 171 127
NOPAT Margin		 2.60% -0.68% -0.50% -4.19% 0.20% 6.70% 7.18% 2.58% 6.01% 10.83% 7.99%
Net Nonoperating Expense Percent (NNEP)		 4.48% 0.23% 0.60% 0.83% -0.71% -0.79% -0.66% -0.12% -1.18% 0.44% -0.10%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 99.34% 97.88% 100.72% 105.98% 99.72% 90.62% 90.94% 96.72% 92.37% 86.55% 90.02%
Earnings before Interest and Taxes (EBIT)		 9.00 32 -10 -90 4.30 142 139 50 118 213 159
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 14 37 -6.20 -86 7.70 145 142 53 120 214 160
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.90 1.95 1.85 1.76 1.83 1.72 1.92 1.77 1.85 1.96 2.05
Price to Tangible Book Value (P/TBV)		 2.06 2.12 2.00 1.91 2.00 1.85 2.06 1.90 1.97 2.09 2.18
Price to Revenue (P/Rev)		 0.83 0.83 0.79 0.67 0.65 0.71 0.80 0.74 0.87 0.90 1.00
Price to Earnings (P/E)		 14.73 39.29 0.00 0.00 0.00 119.96 29.71 16.55 14.56 13.08 14.25
Dividend Yield		 2.45% 2.39% 2.51% 2.89% 3.00% 2.77% 2.46% 2.68% 2.30% 2.23% 2.01%
Earnings Yield		 6.79% 2.55% 0.00% 0.00% 0.00% 0.83% 3.37% 6.04% 6.87% 7.64% 7.02%
Enterprise Value to Invested Capital (EV/IC)		 1.62 1.62 1.58 1.50 1.50 1.45 1.62 1.49 1.55 1.63 1.75
Enterprise Value to Revenue (EV/Rev)		 0.94 0.92 0.89 0.78 0.73 0.79 0.88 0.81 0.93 0.96 1.07
Enterprise Value to EBITDA (EV/EBITDA)		 15.55 22.31 58.78 0.00 0.00 77.20 25.66 14.27 12.37 11.21 12.29
Enterprise Value to EBIT (EV/EBIT)		 16.55 24.29 74.37 0.00 0.00 100.68 27.29 14.75 12.65 11.39 12.44
Enterprise Value to NOPAT (EV/NOPAT)		 17.06 29.95 0.00 0.00 0.00 123.52 34.62 18.81 16.50 14.30 15.58
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.61 6.97 9.29 8.14 9.31 13.00 13.31 9.61 8.29 7.34 8.54
Enterprise Value to Free Cash Flow (EV/FCFF)		 4.53 5.15 11.39 18.36 47.26 0.00 265.32 0.00 0.00 160.17 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.34 0.34 0.33 0.35 0.37 0.32 0.31 0.31 0.27 0.28 0.26
Long-Term Debt to Equity		 0.34 0.34 0.33 0.35 0.37 0.32 0.31 0.31 0.27 0.25 0.24
Financial Leverage		 0.29 0.29 0.30 0.33 0.35 0.33 0.32 0.33 0.31 0.30 0.28
Leverage Ratio		 5.16 5.16 5.35 5.78 6.36 5.96 5.84 6.07 5.94 5.63 5.40
Compound Leverage Factor		 0.29 -2.35 9.00 5.85 -1.33 6.29 6.10 6.20 6.54 5.60 5.43
Debt to Total Capital		 25.41% 25.11% 24.68% 25.91% 27.01% 24.11% 23.70% 23.49% 21.41% 21.63% 20.48%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.70% 1.61%
Long-Term Debt to Total Capital		 25.41% 25.11% 24.68% 25.91% 27.01% 24.11% 23.70% 23.49% 21.41% 19.92% 18.87%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 74.59% 74.89% 75.32% 74.09% 72.99% 75.89% 76.30% 76.51% 78.59% 78.38% 79.52%
Debt to EBITDA		 2.45 3.47 9.16 -18.95 -16.38 12.86 3.75 2.26 1.71 1.48 1.43
Net Debt to EBITDA		 1.93 2.12 7.04 -14.90 -10.22 7.67 2.49 1.28 0.78 0.66 0.86
Long-Term Debt to EBITDA		 2.45 3.47 9.16 -18.95 -16.38 12.86 3.75 2.26 1.71 1.37 1.32
Debt to NOPAT		 2.68 4.65 -319.43 -9.14 -9.04 20.58 5.06 2.98 2.28 1.89 1.82
Net Debt to NOPAT		 2.12 2.84 -245.35 -7.18 -5.64 12.27 3.35 1.69 1.04 0.84 1.09
Long-Term Debt to NOPAT		 2.68 4.65 -319.43 -9.14 -9.04 20.58 5.06 2.98 2.28 1.74 1.68
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 841 800 436 270 182 -31 -24 -276 -669 -206 -395
Operating Cash Flow to CapEx		 7,877.50% 5,089.74% 517.14% 793.94% 7,748.28% 4,213.64% 2,257.69% 6,340.91% 16,445.83% 7,116.67% 2,161.11%
Free Cash Flow to Firm to Interest Expense		 98.96 93.04 51.26 31.44 21.39 -3.64 -2.84 -32.05 -78.75 -24.21 -46.49
Operating Cash Flow to Interest Expense		 37.07 23.08 2.13 3.05 26.44 10.91 6.91 16.22 46.44 25.12 4.58
Operating Cash Flow Less CapEx to Interest Expense		 36.60 22.63 1.72 2.66 26.09 10.65 6.60 15.97 46.15 24.76 4.36
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.38 0.39 0.40 0.42 0.43 0.42 0.42 0.42 0.41 0.41 0.42
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3,078 3,116 3,172 3,021 2,899 3,249 3,306 3,336 3,662 3,626 3,829
Invested Capital Turnover		 1.51 1.56 1.66 1.83 2.00 1.88 1.87 1.92 1.87 1.80 1.75
Increase / (Decrease) in Invested Capital		 -806 -810 -443 -333 -179 133 135 315 762 377 523
Enterprise Value (EV)		 4,974 5,035 5,020 4,543 4,354 4,702 5,355 4,955 5,686 5,922 6,719
Market Capitalization		 4,356 4,558 4,419 3,928 3,866 4,235 4,836 4,509 5,330 5,573 6,249
Book Value per Share		 $64.43 $65.62 $67.10 $62.64 $59.19 $68.94 $70.47 $71.01 $79.97 $78.87 $84.74
Tangible Book Value per Share		 $59.41 $60.60 $62.08 $57.64 $54.19 $63.94 $65.47 $66.03 $75.00 $73.90 $79.76
Total Capital		 3,078 3,116 3,172 3,021 2,899 3,249 3,306 3,336 3,662 3,626 3,829
Total Debt		 782 782 783 783 783 783 783 784 784 784 784
Total Long-Term Debt		 782 782 783 783 783 783 783 784 784 722 723
Net Debt		 617 477 601 615 489 467 519 446 357 349 469
Capital Expenditures (CapEx)		 4.00 3.90 3.50 3.30 2.90 2.20 2.60 2.20 2.40 3.00 1.80
Net Nonoperating Expense (NNE)		 35 1.81 4.72 6.48 -5.59 -6.17 -5.17 -0.97 -9.21 3.43 -0.80
Net Nonoperating Obligations (NNO)		 782 782 783 783 783 783 783 784 784 784 784
Total Depreciation and Amortization (D&A)		 5.20 4.30 4.20 3.80 3.40 2.80 2.50 2.50 2.20 1.10 0.50
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.01 ($0.34) ($0.34) ($1.94) $0.24 $3.03 $3.22 $1.13 $2.84 $4.66 $3.56
Adjusted Weighted Average Basic Shares Outstanding		 35.60M 35.60M 35.60M 35.70M 35.80M 35.70M 35.80M 36M 36M 35.90M 36M
Adjusted Diluted Earnings per Share		 $0.01 ($0.33) ($0.34) ($1.94) $0.24 $3.02 $3.18 $1.12 $2.80 $4.60 $3.50
Adjusted Weighted Average Diluted Shares Outstanding		 36.10M 36.10M 35.60M 35.70M 36.10M 36.10M 36.30M 36.30M 36.50M 36.40M 36.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 35.56M 35.60M 35.73M 35.75M 35.76M 35.82M 35.94M 35.98M 36.03M 35.93M 35.92M
Normalized Net Operating Profit after Tax (NOPAT)		 21 -10 -7.28 -62 3.01 102 110 42 93 171 127
Normalized NOPAT Margin		 1.52% -0.68% -0.50% -4.11% 0.20% 6.70% 7.18% 2.76% 6.04% 10.83% 7.99%
Pre Tax Income Margin		 0.04% -0.97% -1.21% -6.05% -0.06% 9.89% 9.46% 3.35% 8.39% 13.36% 10.05%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.06 3.74 -1.22 -10.42 0.51 16.75 16.36 5.84 13.87 25.04 18.72
NOPAT to Interest Expense		 4.18 -1.20 -0.86 -7.29 0.35 11.97 12.98 4.60 10.93 20.16 14.99
EBIT Less CapEx to Interest Expense		 0.59 3.29 -1.64 -10.80 0.16 16.49 16.06 5.58 13.59 24.68 18.51
NOPAT Less CapEx to Interest Expense		 3.71 -1.65 -1.27 -7.68 0.01 11.71 12.67 4.34 10.65 19.80 14.78
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 36.08% 93.88% -12,344.44% -122.20% -136.60% 332.01% 72.97% 44.18% 33.33% 29.13% 28.72%
Augmented Payout Ratio		 53.26% 120.43% -13,955.56% -133.41% -136.60% 332.01% 72.97% 44.18% 33.33% 35.40% 37.31%

Key Financial Trends

The Hanover Insurance Group (NYSE: THG) has exhibited a complex financial performance over the last four years, with a mixed but generally improving trend in profitability, revenue, and cash flows, alongside stable asset and equity base growth.

Positive financial highlights include:

  • Consistent earnings improvement from a net loss of $69.2 million in Q2 2023 to a net income of $128.2 million in Q1 2025, reflecting a significant turnaround in profitability.
  • Steady growth in premium income, reaching $1.51 billion in Q1 2025, indicating a strong core insurance business.
  • Strong net realized and unrealized capital gains on investments, peaking at $87.3 million in Q1 2025, supporting non-interest income growth.
  • Increasing total assets from approximately $13.7 billion in Q3 2022 to $15.5 billion in Q1 2025, showing balance sheet expansion.
  • Growth in total equity from around $2.3 billion in Q3 2022 to $3.0 billion in Q1 2025, signifying strengthened shareholder value.
  • Improvement in net cash from operating activities, which, despite fluctuations, remained positive and reached $38.9 million in Q1 2025, reflecting operating cash flow resilience.
  • Stable dividend payments around $30 million per quarter, marking consistent shareholder returns.
  • Reduction in impairment charges to minimal levels by recent quarters, reflecting improved asset quality or lower write-downs.

Neutral points that should be monitored:

  • Interest expense on long-term debt remains stable at approximately $8.5 million per quarter, consistent but a fixed cost burden.
  • Amortization expense is steady around $300 million each quarter, indicating significant intangible asset amortization impacting profitability.
  • Fluctuations in net cash from investing activities reflect ongoing investment portfolio purchases and sales typical for insurance companies.
  • Cash and cash equivalents vary quarter to quarter but have somewhat increased from approx. $165 million in Q3 2022 to $315 million in Q1 2025, showing liquidity management.

Challenges and potential negative impacts:

  • The company experienced net losses for several quarters in 2023, highlighting operational struggles during that period.
  • Other operating expenses and claims & claim expenses remain sizeable at approximately $160 million and up to $1 billion per quarter, creating sustained pressure on margins.
  • Accumulated other comprehensive loss remains elevated (over $300 million negative), which may affect comprehensive income and indicates volatility in certain non-operating items.
  • Net cash from financing activities involves regular cash outflows due to dividends and common stock repurchases, which could constrain cash flow flexibility.
  • Unearned premium liabilities have generally increased, representing future obligations and reserving requirements that impact liquidity and capital.

Summary: Hanover Insurance Group has made notable strides improving profitability and bolstering its equity base after a challenging 2023 marked by losses. Premium growth and investment income gains underpin its revenue resilience. However, the company faces ongoing cost pressures from claims and operating expenses, and its leverage and comprehensive loss accounts require attentive management. Investors should monitor quarterly results for sustained earnings growth, expense control, and capital position improvements to assess future stock performance potential.

08/08/25 09:12 AMAI Generated. May Contain Errors.

Frequently Asked Questions About The Hanover Insurance Group's Financials

When does The Hanover Insurance Group's fiscal year end?

According to the most recent income statement we have on file, The Hanover Insurance Group's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has The Hanover Insurance Group's net income changed over the last 9 years?

The Hanover Insurance Group's net income were at $426 million at the end of 2024, a 1,106.8% increase from 2023, and a 28.5% increase since 2015. View The Hanover Insurance Group's forecast to see where analysts expect The Hanover Insurance Group to go next.

How has The Hanover Insurance Group's revenue changed over the last 9 years?

Over the last 9 years, The Hanover Insurance Group's total revenue changed from $4.99 billion in 2015 to $6.19 billion in 2024, a change of 24.2%.

How much debt does The Hanover Insurance Group have?

The Hanover Insurance Group's total liabilities were at $12.43 billion at the end of 2024, a 2.4% increase from 2023, and a 13.7% increase since 2015.

How much cash does The Hanover Insurance Group have?

In the past 9 years, The Hanover Insurance Group's cash and equivalents has ranged from $120.60 million in 2020 to $1.02 billion in 2018, and is currently $435.50 million as of their latest financial filing in 2024.

How has The Hanover Insurance Group's book value per share changed over the last 9 years?

Over the last 9 years, The Hanover Insurance Group's book value per share changed from 65.77 in 2015 to 78.87 in 2024, a change of 19.9%.


Related Companies

This page (NYSE:THG) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsored
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...
Brownstone Research | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
Critical AI announcement set to ignite AI 2.0
A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...
Timothy Sykes | Sponsored
Trump’s new nightmare
According to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...
Porter & Company | Sponsored
The Day Silicon Dies
The Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...
The Oxford Club | Sponsored
This accelerated income plan is solving American's #1 retirement fear
The #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...
Investors Alley | Sponsored
Sell this, buy that
What you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...
InvestorPlace | Sponsored